Citation: Qian Wang, Yeping Bian, Gagan Dhawan, Wei Zhang, Alexander E. Sorochinsky, Ata Makarem, Vadim A. Soloshonok, Jianlin Han. FDA approved fluorine-containing drugs in 2023[J]. Chinese Chemical Letters, ;2024, 35(11): 109780. doi: 10.1016/j.cclet.2024.109780 shu

FDA approved fluorine-containing drugs in 2023

Qian Wang ^a ,
Yeping Bian ^{b, *,} ,
Gagan Dhawan ^{c, *,} ,
Wei Zhang ^{d, *,} ,
Alexander E. Sorochinsky ^{e, *,} ,
Ata Makarem ^f ,
Vadim A. Soloshonok ^{g, h, **,} ,
Jianlin Han ^{a, *,}

a.
Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China
b.
Jiangsu Province Geriatric Hospital, Nanjing 210024, China
c.
School of Allied Medical Sciences, Delhi Skill and Entrepreneurship University, and Department of Biomedical Science, Acharya Narendra Dev College, University of Delhi, New Delhi 110019, India
d.
Department of Chemistry, University of Massachusetts Boston, Boston, MA 02125, United States
e.
V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, The National Academy of Sciences of Ukraine, Kyiv 02094, Ukraine
f.
Department of Chemistry, University of Hamburg, Martin-Luther-King-Platz 6, Hamburg 20146, Germany
g.
Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizábal 3, San Sebastián 20018, Spain
h.
IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, Plaza Bizkaia, Bilbao 48013, Spain

^**

bianyeping@jspgh.com

gagandhawan@andc.du.ac.in

wei2.zhang@umb.edu

sorochinsky.a@gmail.com

vadym.soloshonok@ehu.es

hanjl@njfu.edu.cn

Received Date: 12 January 2024
Revised Date: 2 March 2024
Accepted Date: 14 March 2024
Available Online: 15 March 2024

Figures(24)

This review profiles twelve fluorine-containing drugs approved by the US Food and Drug Administration (FDA) for the clinic in 2023. These small molecule drugs represent such therapeutic areas as cancer, neuromuscular disorder, immunodeficiency, virology, and infectious diseases. Medicinal chemistry discovery, biological activity, and synthetic routes have been discussed for each drug. Also, new trends in structural positioning, functionality, and degree of fluorination are discussed. Besides fluorination, the importance of amino acid residues and chirality in the design of new pharmaceuticals is highlighted.
- Fluorine-containing compounds,
- Blockbuster drugs,
- Pharmaceuticals,
- Anti-cancer,
- Drug design and development,
- Asymmetric synthesis
1. [1]
  J. Fried, E.F. Sabo, J. Am. Chem. Soc. 75 (1953) 2273–2274. doi: 10.1021/ja01105a527
2. [2]
  J. Fried, E.F. Sabo, J. Am. Chem. Soc. 76 (1954) 1455–1456.
3. [3]
  X.Y. Yang, T. Wu, R.J. Phipps, F.D. Toste, Chem. Rev. 115 (2015) 826–870. doi: 10.1021/cr500277b
4. [4]
  R.G. Syvret, K.M. Butt, T.P. Nguyen, V.L. Bulleck, R.D. Rieth, J. Org. Chem. 67 (2002) 4487–4493. doi: 10.1021/jo020053u
5. [5]
  P. Bravo, S. Capelli, S.V. Meille, et al., Tetrahedron Asymmetry 5 (1994) 2009–2018. doi: 10.1016/S0957-4166(00)86276-X
6. [6]
  X. Xu, K. Matsuzaki, N. Shibata, Chem. Rev. 115 (2015) 731–764. doi: 10.1021/cr500193b
7. [7]
  H. Ohkura, D.O. Berbasov, V.A. Soloshonok, Tetrahedron 59 (2003) 1647–1656. doi: 10.1016/S0040-4020(03)00138-8
8. [8]
  K. Gondo, T. Kitamura, Molecules 17 (2012) 6625–6632. doi: 10.3390/molecules17066625
9. [9]
  J. Han, A.E. Sorochinsky, T. Ono, V.A. Soloshonok, Curr. Org. Synth. 8 (2011) 281–294. doi: 10.2174/157017911794697277
10. [10]
  R.G. Syvret, W.J. Casteel, G.S. Lal, J.S. Goudar, J. Fluor. Chem. 125 (2004) 33–35. doi: 10.1016/j.jfluchem.2003.09.002
11. [11]
  G.V. Röschenthaler, V.P. Kukhar, I.B. Kulik, et al., Tetrahedron Lett. 53 (2012) 539–542. doi: 10.1016/j.tetlet.2011.11.096
12. [12]
  M.S. Wiehn, E.V. Vinogradova, A. Togni, J. Fluor. Chem. 131 (2010) 951–957. doi: 10.1016/j.jfluchem.2010.06.020
13. [13]
  M. Shevchuk, Q. Wang, R. Pajkert, et al., Adv. Synth. Catal. 363 (2021) 2912–2968. doi: 10.1002/adsc.202001464
14. [14]
  E. Merino, C. Nevado, Chem. Soc. Rev. 43 (2014) 6598–6608. doi: 10.1039/C4CS00025K
15. [15]
  J.A. Ma, D. Cahard, J. Fluor. Chem. 128 (2007) 975–996. doi: 10.1016/j.jfluchem.2007.04.026
16. [16]
  F.L. Qing, X.Y. Liu, J.A. Ma, et al., CCS Chem. 4 (2022) 2518–2549. doi: 10.31635/ccschem.022.202201935
17. [17]
  S.S. Li, J. Wang, Acta Chim. Sin. 76 (2018) 913–924. doi: 10.6023/A18070306
18. [18]
  J. Hu, K. Ding, Acta Chim. Sin. 76 (2018) 905–906. doi: 10.6023/A1812E001
19. [19]
  M. Reichel, K. Karaghiosoff, Angew. Chem. Int. Ed. 59 (2020) 12268–12281. doi: 10.1002/anie.201913175
20. [20]
  Y. Kraemer, E.N. Bergman, A. Togni, C.R. Pitts, Angew. Chem. Int. Ed. 61 (2022) e202205088. doi: 10.1002/anie.202205088
21. [21]
  J. Wang, M. Sánchez-Roselló, J.L. Aceña, et al., Chem. Rev. 114 (2014) 2432–2506. doi: 10.1021/cr4002879
22. [22]
  Y. Zhou, J. Wang, Z. Gu, et al., Chem. Rev. 116 (2016) 422–518. doi: 10.1021/acs.chemrev.5b00392
23. [23]
  Y. Zhu, J. Han, J. Wang, et al., Chem. Rev. 118 (2018) 3887–3964. doi: 10.1021/acs.chemrev.7b00778
24. [24]
  J. Han, L. Kiss, H. Mei, et al., Chem. Rev. 121 (2021) 4678–4742. doi: 10.1021/acs.chemrev.0c01263
25. [25]
  H. Mei, J. Han, K.D. Klika, et al., Eur. J. Med. Chem. 186 (2020) 111826. doi: 10.1016/j.ejmech.2019.111826
26. [26]
  H. Mei, J. Han, S. White, et al., Chem. Eur. J. 26 (2020) 11349–11390. doi: 10.1002/chem.202000617
27. [27]
  H. Mei, J. Han, S. Fustero, et al., Chem. Eur. J. 25 (2019) 11797–11819. doi: 10.1002/chem.201901840
28. [28]
  H. Mei, A.M. Remete, Y. Zou, et al., Chin. Chem. Lett. 31 (2020) 2401–2413. doi: 10.1016/j.cclet.2020.03.050
29. [29]
  S. Purser, P.R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 37 (2008) 320–330. doi: 10.1039/B610213C
30. [30]
  C. Isanbor, D. O’Hagan, J. Fluor. Chem. 127 (2006) 303–319. doi: 10.1016/j.jfluchem.2006.01.011
31. [31]
  Q. Wang, H. Song, Q. Wang, Chin. Chem. Lett. 33 (2022) 626–642. doi: 10.1016/j.cclet.2021.07.064
32. [32]
  Y. Ogawa, E. Tokunaga, O. Kobayashi, K. Hirai, N. Shibata, iScience 23 (2020) 101467. doi: 10.1016/j.isci.2020.101467
33. [33]
  T. Fujiwara, D. O’Hagan, J. Fluor. Chem. 167 (2014) 16–29. doi: 10.1016/j.jfluchem.2014.06.014
34. [34]
  C. Qin, W. Liu, Y. Nie, et al., Chin. J. Org. Chem. 40 (2020) 2232–2253. doi: 10.6023/cjoc202003051
35. [35]
  N. Wang, H. Mei, G. Dhawan, et al., Molecule 28 (2023) 3651. doi: 10.3390/molecules28093651
36. [36]
  Q. Wang, J. Han, A. Sorochinsky, et al., Pharmaceuticals 15 (2022) 999. doi: 10.3390/ph15080999
37. [37]
  E.P. Gillis, K.J. Eastman, M.D. Hill, D.J. Donnelly, N.A. Meanwell, J. Med. Chem. 58 (2015) 8315–8359. doi: 10.1021/acs.jmedchem.5b00258
38. [38]
  I. Ojima, J. Fluor. Chem. 198 (2017) 10–23. doi: 10.1016/j.jfluchem.2016.12.016
39. [39]
  J. Han, A.M. Remete, L.S. Dobson, et al., J. Fluor. Chem. 239 (2020) 109639. doi: 10.1016/j.jfluchem.2020.109639
40. [40]
  D. O’Hagan, J. Fluor. Chem. 131 (2010) 1071–1081. doi: 10.1016/j.jfluchem.2010.03.003
41. [41]
  Y. Yu, A. Liu, G. Dhawan, et al., Chin. Chem. Lett. 32 (2021) 3342–3354. doi: 10.1016/j.cclet.2021.05.042
42. [42]
  J. He, Z. Li, G. Dhawan, et al., Chin. Chem. Lett. 34 (2023) 107578. doi: 10.1016/j.cclet.2022.06.001
43. [43]
  B. Aslan, G. Kismali, L.R. Iles, et al., Blood Cancer J. 12 (2022) 80.
44. [44]
  E.B. Gomez, K. Ebata, H.S. Randeria, et al., Blood 142 (2023) 62–72. doi: 10.1182/blood-2023-183029
45. [45]
  P. Thompson, C. Tam, Blood 141 (2023) 3137–3142.
46. [46]
  D. Telaraja, Y.L. Kasamon, J.S. Collazo, et al., Clin. Cancer Res. 30 (2024) 17–22. doi: 10.1158/1078-0432.CCR-23-1272
47. [47]
  A.R. Mato, N.V. Shah, W. Jurczak, et al., Lancet 397 (2021) 892–901. doi: 10.1016/S0140-6736(21)00224-5
48. [48]
  S.J. Keam, Drugs 83 (2023) 547–553. doi: 10.1007/s40265-023-01860-1
49. [49]
  D. Arguelles, J. Alonso, C.T. Eary, et al., Patent, WO 2022056100 A1, 2022.
50. [50]
  A. Cuadrado, G. Manda, A. Hassan, et al., Pharmacol. Rev. 70 (2018) 348–383. doi: 10.1124/pr.117.014753
51. [51]
  S. Saha, B. Buttari, E. Panieri, E. Profumo, L. Saso, Molecules 25 (2020) 5474. doi: 10.3390/molecules25225474
52. [52]
  R. Borella, L. Forti, L. Gibellini, et al., Molecules 24 (2019) 4097. doi: 10.3390/molecules24224097
53. [53]
  T. Shekh-Ahmad, R. Eckel, S.D. Naidu, et al., Brain 141 (2018) 1390–1403. doi: 10.1093/brain/awy071
54. [54]
  H. Sun, J. Zhu, H. Lin, K. Gu, F. Feng, Expert Opin. Ther. Pat. 27 (2017) 763–785. doi: 10.1080/13543776.2017.1325464
55. [55]
  A. Lee, Drugs 83 (2023) 725–729. doi: 10.1007/s40265-023-01874-9
56. [56]
  V. Profeta, K. McIntyre, M. Wells, C. Park, D.R. Lynch, Expert Opin. Investig. 32 (2023) 5–16. doi: 10.1080/13543784.2023.2173063
57. [57]
  E. Anderson, A. Decker, X. Liu, Patent, WO 2013163344 A1, 2013.
58. [58]
  M.B. Sporn, K.T. Liby, M.M. Yore, et al., J. Nat. Prod. 74 (2011) 537–545. doi: 10.1021/np100826q
59. [59]
  K. Hoegenauer, N. Soldermann, F. Zécri, et al., ACS Med. Chem. Lett. 8 (2017) 975–980. doi: 10.1021/acsmedchemlett.7b00293
60. [60]
  C. Bauer, T. Luu, F. Eggimann, et al., Helv. Chim. Acta 101 (2018) e1800044. doi: 10.1002/hlca.201800044
61. [61]
  Z. Wu, X. Li, X. Chen, et al., Front. Pharmacol. 13 (2022) 1021714.
62. [62]
  J. Zhang, H. Jiang, S. Lin, et al., J. Med. Chem. 65 (2022) 8011–8028. doi: 10.1021/acs.jmedchem.2c00530
63. [63]
  S. Duggan, Z.T. Al–Salama, Drugs 83 (2023) 943–948. doi: 10.1007/s40265-023-01895-4
64. [64]
  P.A. Fernandes Gomes Dos Santos, K. Högenauer, G. Holling-Worth, et al., Patent, WO 2013001445 A1, 2013.
65. [65]
  N.G. Cooke, P.A. Fernandes Gomes Dos Santos, P. Furet, et al., Patent, WO 2013088404 A1, 2013.
66. [66]
  M. Beier, D. Willen, S. Krösser, T. Schlüter, Patent, WO 2020058504 A1, 2020.
67. [67]
  T. Keller, D. Röthlein, J. Schmitt, et al., Patent, WO 2014154531 A1, 2014.
68. [68]
  P. Ivanov Bichovski, F. Löscher, S. Nicoletti, Patent, WO 2018228975 A1, 2018.
69. [69]
  A. Ballesteros-Sánchez, C. De-Hita-Cantalejo, M.C. Sánchez-González, et al., Ocul. Surf. 30 (2023) 254–262. doi: 10.1016/j.jtos.2023.10.001
70. [70]
  Y.K. Kim, B. Gonther, H. Meinert, Eur. J. Ophthalmol. 15 (2005) 627–637. doi: 10.1177/112067210501500514
71. [71]
  T.D. Le, R.A. Arlauskas, J.G. Weers, J. Fluor. Chem. 78 (1996) 153–156.
72. [72]
  S. Barata-Vallejo, A. Postigo, J. Org. Chem. 75 (2010) 6141–6148. doi: 10.1021/jo100901z
73. [73]
  H. Depypere, D. Timmerman, G. Donders, et al., J. Clin. Endocr. Metab. 104 (2019) 5893–5905. doi: 10.1210/jc.2019-00677
74. [74]
  H.R. Hoveyda, G.L. Fraser, M.O. Roy, et al., J. Med. Chem. 58 (2015) 3060–3082. doi: 10.1021/jm5017413
75. [75]
  H.R. Hoveyda, G.L. Fraser, G. Dutheuil, et al., ACS Med. Chem. Lett. 6 (2015) 736–740. doi: 10.1021/acsmedchemlett.5b00117
76. [76]
  A. Lee, Drugs 83 (2023) 1137–1141. doi: 10.1007/s40265-023-01917-1
77. [77]
  A.N. Comninos, W.S. Dhillo, Cell 186 (2023) 3332-3332.e1. doi: 10.1016/j.cell.2023.07.011
78. [78]
  H. Hoveyda, G. Dutheuil, G. Fraser, et al., Patent, WO 201305424 A1, 2013.
79. [79]
  J. Gerhart, D.S. Cox, R.S.P. Singh, et al., Clin. Pharmacokinet. 63 (2024) 27–42. doi: 10.1007/s40262-023-01339-y
80. [80]
  K. Anand, J. Ziebuhr, P. Wadhwani, J.R. Mesters, R. Hilgenfeld, Science 300 (2003) 1763–1767. doi: 10.1126/science.1085658
81. [81]
  J. Hammond, H. Leister-Tebbe, A. Gardner, et al., N. Engl. J. Med. 386 (2022) 1397–1408. doi: 10.1056/NEJMoa2118542
82. [82]
  D.R. Owen, C.M.N. Allerton, A.L.S. Anderson, et al., Science 374 (2021) 1586–1593. doi: 10.1126/science.abl4784
83. [83]
  I.F. Sevrioukova, T.L. Poulos, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 18422–18427. doi: 10.1073/pnas.1010693107
84. [84]
  C. Shekhar, R. Nasam, S.R. Paipuri, et al., Tetrahedron Chem. 4 (2022) 100033. doi: 10.1016/j.tchem.2022.100033
85. [85]
  Y.R. Alugubelli, Z.Z. Geng, K.S. Yang, et al., Eur. J. Med. Chem. 240 (2022) 114596. doi: 10.1016/j.ejmech.2022.114596
86. [86]
  D.R. Owen, M.Y. Pettersson, M.R. Reese, et al., Patent, US 11351149 B2, 2022.
87. [87]
  D.R. Owen, M.Y. Pettersson, M.R. Reese, et al., Patent, WO 2021250648 A1, 2021.
88. [88]
  B.A. Cotrim, J.C. Barros, Aust. J. Chem. 75 (2022) 487–491. doi: 10.1071/CH22104
89. [89]
  W.L. Shoop, E.J. Hartline, B.R. Gould, et al., Vet. Parasitol. 201 (2014) 179–189. doi: 10.1016/j.vetpar.2014.02.020
90. [90]
  M.P. Curtis, V. Vaillancourt, R.M. Goodwin, et al., Bioorg. Med. Chem. Lett. 26 (2016) 1831–1835. doi: 10.1016/j.bmcl.2016.02.027
91. [91]
  L. Rufener, V. Danelli, D. Bertrand, et al., Parasites Vectors 10 (2017) 530. doi: 10.1186/s13071-017-2470-4
92. [92]
  Y.Y. Gao, M.A. Di Pascuale, W. Li, et al., Investig. Ophthalmol. Vis. Sci. 46 (2005) 3089–3094. doi: 10.1167/iovs.05-0275
93. [93]
  W. Trattler, P. Karpecki, Y. Rapoport, et al., Clin. Ophthalmol. 16 (2022) 1153–1164. doi: 10.2147/OPTH.S354692
94. [94]
  L. O’Dell, D.S. Dierker, D.K. Devries, et al., Clin. Ophthalmol. 16 (2022) 2979–2987. doi: 10.2147/OPTH.S374530
95. [95]
  E. Yeu, D.L. Wirta, P. Karpecki, et al., Cornea 42 (2022) 435–443.
96. [96]
  C.E. Toutain, W. Seewald, M. Jung, Parasites Vectors 11 (2018) 412. doi: 10.1186/s13071-018-2966-6
97. [97]
  C.E. Toutain, W. Seewald, M. Jung, Parasites Vectors 10 (2017) 522. doi: 10.1186/s13071-017-2475-z
98. [98]
  L. Rufener, V. Danelli, D. Bertrand, H. Sager, Parasites Vectors 10 (2017) 530. doi: 10.1186/s13071-017-2470-4
99. [99]
  N. Lamassiaude, B. Toubate, C. Neveu, et al., PLoS Pathog. 17 (2021) e1008863. doi: 10.1371/journal.ppat.1008863
100. [100]
  S. Nanchen, Patent, WO2014090918 A1, 2014.
101. [101]
  S. Dhillon, Drugs 24 (2024), doi: 10.1007/s40265-023-01990-6.
102. [102]
  A. Drilon, S.H.I. Ou, B.C. Cho, et al., Cancer Discov. 8 (2018) 1227–1236. doi: 10.1158/2159-8290.CD-18-0484
103. [103]
  J.J. Cui, Y. Li, E.W. Rogers, Patent, WO2017004342 A1, 2017.
104. [104]
  J. Li, D. Zhang, J. Feng, et al., Patent, WO2019201282 A1, 2019.
105. [105]
  J.A. Ellman, Pure Appl. Chem. 75 (2023) 39–46.
106. [106]
  M.T. Robak, M.A. Herbage, J.A. Ellman, Chem. Rev. 110 (2010) 3600–3740. doi: 10.1021/cr900382t
107. [107]
  C. Xie, L. Wu, H. Mei, Org. Biomol. Chem. 12 (2014) 7836–7843. doi: 10.1039/C4OB01575D
108. [108]
  J.L. Moore, S.M. Taylor, V.A. Soloshonok, Arkivoc 6 (2005) 287–292.
109. [109]
  S. Chen, J. Xu, Tetrahedron Lett. 32 (1991) 6711–6714. doi: 10.1016/S0040-4039(00)93583-4
110. [110]
  L. Xu, G. Wang, N. Rong, et al., Org. Process Res. Dev. (2023), doi: 10.1021/acs.oprd.3c00152. doi: 10.1021/acs.oprd.3c00152
111. [111]
  A.E. Sorochinsky, J.L. Aceña, V.A. Soloshonok, Synthesis 45 (2013) 141–152.
112. [112]
  T. Nakamura, K. Tateishi, S. Tsukagoshi, et al., Tetrahedron 68 (2012) 4013–4017. doi: 10.1016/j.tet.2012.03.054
113. [113]
  Y. Suzuki, J. Han, O. Kitagawa, et al., RSC Adv. 5 (2015) 2988–2993. doi: 10.1039/C4RA13928C
114. [114]
  M.A. Brodney, D.D. Auperin, S.L. Becker, et al., Bioorg. Med. Chem. Lett. 21 (2011) 2637–2640. doi: 10.1016/j.bmcl.2010.12.118
115. [115]
  T. Takahashi, J.R. Prensner, C.D. Robson, K.A. Janeway, B.J. Weigel, Pediatr. Blood Cancer 67 (2020) e28636. doi: 10.1002/pbc.28636
116. [116]
  S. Lonial, S. Grosicki, M. Hus, et al., J. Clin. Oncol. 40 (2022) 8019. doi: 10.1200/JCO.2022.40.16_suppl.8019
117. [117]
  M. Gounder, R. Ratan, T. Alcindor, et al., N. Engl. J. Med. 388 (2023) 898–912. doi: 10.1056/NEJMoa2210140
118. [118]
  K. Patterson, M. Hatcher, Patent, WO 2023034917 A1, 2023.
119. [119]
  E. Jonasch, F. Donskov, O. Iliopoulos, et al., N. Engl. J. Med. 385 (2021) 2036–2046. doi: 10.1056/NEJMoa2103425
120. [120]
  T.K. Choueiri, T.M. Bauer, K.P. Papadopoulos, et al., Nat. Med. 27 (2021) 802–805. doi: 10.1038/s41591-021-01324-7
121. [121]
  V. Visweswaran, K. Pavithran, Curr. Drug Res. Rev. 14 (2022) 88–95. doi: 10.2174/2589977514666220401094724
122. [122]
  R. Xu, K. Wang, J.P. Rizzi, et al., J. Med. Chem. 62 (2019) 6876–6893. doi: 10.1021/acs.jmedchem.9b00719
123. [123]
  E.D. Deeks, Drugs 81 (2021) 1921–1927. doi: 10.1007/s40265-021-01606-x
124. [124]
  K.B. Hamal, C.I. Pavlich, G.J. Carlson, et al., Tetrahedron Lett. 128 (2023) 154691. doi: 10.1016/j.tetlet.2023.154691
125. [125]
  J.P. Bégué, D. Bonnet-Delpon, J. Fluor. Chem. 127 (2006) 992–1012. doi: 10.1016/j.jfluchem.2006.05.006
126. [126]
  S. Akyuz, A.E. Ozel, K. Balci, et al., J. Mol. Struct. 993 (2011) 319–323. doi: 10.1016/j.molstruc.2011.01.041
127. [127]
  M. Boberg, A.C. Jonson, H. Leek, R. Jansson-Löfmark, M. Ashton, ACS Omega 5 (2020) 23885–23891. doi: 10.1021/acsomega.0c03121
128. [128]
  B.W. Metcalf, P. Bey, C. Danzin, et al., J. Am. Chem. Soc. 100 (1978) 2551–2553. doi: 10.1021/ja00476a050
129. [129]
  C. Burri, R. Brun, Parasitol. Res. 90 (2003) S49–S52. doi: 10.1007/s00436-002-0766-5
130. [130]
  B. Bouteille, O. Oukem, S. Bisser, M. Dumas, Fundam. Clin. Pharmacol. 17 (2003) 171–181. doi: 10.1046/j.1472-8206.2003.00167.x
131. [131]
  M.P. Barrett, I.M. Vincent, R.J.S. Burchmore, A.J.N. Kazibwe, E. Matovu, Future Microbiol. 6 (2011) 1037–1047. doi: 10.2217/fmb.11.88
132. [132]
  J. Zhu, B.A. Price, J. Walker, S.X. Zhao, Tetrahedron Lett. 46 (2005) 2795–2797. doi: 10.1016/j.tetlet.2005.02.146
133. [133]
  K.P. Garnock-Jones, Drugs 75 (2015) 1645–1656. doi: 10.1007/s40265-015-0463-1
134. [134]
  M. Sanford, Drugs 70 (2010) 1615–1627. doi: 10.2165/11205930-000000000-00000
135. [135]
  A. Hatzelmann, E.J. Morcillo, G. Lungarella, et al., Pulm. Pharmacol. Ther. 23 (2010) 235–256. doi: 10.1016/j.pupt.2010.03.011
136. [136]
  M.A. Giembycz, S.K. Field, Drug Des. Dev. Ther. 4 (2010) 147–158.
137. [137]
  K.F. Rabe, Br. J. Pharmacol. 163 (2011) 53–67. doi: 10.1111/j.1476-5381.2011.01218.x
138. [138]
  L.A. Sorbera, P.A. Leeson, J. Castaner, Drug Future 25 (2000) 1261–1264. doi: 10.1358/dof.2000.025.12.604045
139. [139]
  G.L. Card, B.P. England, Y. Suzuki, et al., Structure 12 (2004) 2233–2247. doi: 10.1016/j.str.2004.10.004
140. [140]
  A. Hermann, Patent, WO9501338 A1, 1993.
141. [141]
  Y.J. Chen, S. Pikul, S.C. Kuo, G.D. Chu, Patent, WO 2013131484 A1, 2013.
142. [142]
  Y.J. Chen, S. Pikul, Patent, WO 2013131255 A1, 2013.
143. [143]
  P. Vijaykar, D. Kokane, S. Gharat, et al., Patent, US 20140275551 A1, 2014.
144. [144]
  Y. Lin, P. Huang, S. Liu, et al., Res. Chem. Intermed. 39 (2013) 2107–2113. doi: 10.1007/s11164-012-0742-3
145. [145]
  G. Amari, E. Armani, E. Ghidini, Patent, US 20080015226 A1, 2008.
146. [146]
  J. Han, O. Kitagawa, A. Wzorek, K.D. Klika, V.A. Soloshonok, Chem. Sci. 9 (2018) 1718–1739. doi: 10.1039/C7SC05138G
147. [147]
  J. Han, D.J. Nelson, A.E. Sorochinsky, V.A. Soloshonok, Curr. Org. Synth. 8 (2011) 310–317. doi: 10.2174/157017911794697303
148. [148]
  A.E. Sorochinsky, T. Katagiri, T. Ono, et al., Chirality 25 (2013) 365–368. doi: 10.1002/chir.22180
149. [149]
  H. Ueki, M. Yasumoto, V.A. Soloshonok, Tetrahedron Asymmetry 21 (2010) 1396–1400. doi: 10.1016/j.tetasy.2010.04.040
150. [150]
  J. Han, A. Wzorek, K.D. Klika, V.A. Soloshonok, Molecules 26 (2021) 2757. doi: 10.3390/molecules26092757
151. [151]
  J. Han, R. Dembinski, V.A. Soloshonok, K.D. Klika, Molecules 26 (2021) 3994. doi: 10.3390/molecules26133994
1. [1]
  Tao Yu , Vadim A. Soloshonok , Zhekai Xiao , Hong Liu , Jiang Wang . Probing the dynamic thermodynamic resolution and biological activity of Cu(Ⅱ) and Pd(Ⅱ) complexes with Schiff base ligand derived from proline. Chinese Chemical Letters, 2024, 35(4): 108901-. doi: 10.1016/j.cclet.2023.108901
2. [2]
  Menglu Guo , Ying-Qi Song , Junfei Cheng , Guoqiang Dong , Xun Sun , Chunquan Sheng . Hydrophobic tagging-induced degradation of NAMPT in leukemia cells. Chinese Chemical Letters, 2024, 35(9): 109392-. doi: 10.1016/j.cclet.2023.109392
3. [3]
  Deli Chen , Jiawen Li , Xudong Xu , Zhaocui Sun , Yun Yang , Minghui Xu , Hanqiao Liang , Junshan Yang , Hui Meng , Guoxu Ma , Jianhe Wei . Plant-microbial interactions inspired the discovery of novel sesquiterpenoid dimeric skeletons of hidden natural products from Hibiscus tiliaceus. Chinese Chemical Letters, 2024, 35(10): 109451-. doi: 10.1016/j.cclet.2023.109451
4. [4]
  Renxiao Liang , Zhe Zhong , Zhangling Jin , Lijuan Shi , Yixia Jia . A Palladium/Chiral Phosphoric Acid Relay Catalysis for the One-Pot Three-Step Synthesis of Chiral Tetrahydroquinoline. University Chemistry, 2024, 39(5): 209-217. doi: 10.3866/PKU.DXHX202311024
5. [5]
  Long Jin , Jian Han , Dongmei Fang , Min Wang , Jian Liao . Pd-catalyzed asymmetric carbonyl alkynylation: Synthesis of axial chiral ynones. Chinese Chemical Letters, 2024, 35(6): 109212-. doi: 10.1016/j.cclet.2023.109212
6. [6]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
7. [7]
  Xiang Huang , Dongzhen Xu , Yang Liu , Xia Huang , Yangfan Wu , Dongmei Fang , Bing Xia , Wei Jiao , Jian Liao , Min Wang . Asymmetric synthesis of difluorinated α-quaternary amino acids (DFAAs) via Cu-catalyzed difluorobenzylation of aldimine esters. Chinese Chemical Letters, 2024, 35(12): 109665-. doi: 10.1016/j.cclet.2024.109665
8. [8]
  Wei Sun , Anjing Liao , Li Lei , Xu Tang , Ya Wang , Jian Wu . Research progress on piperidine-containing compounds as agrochemicals. Chinese Chemical Letters, 2025, 36(1): 109855-. doi: 10.1016/j.cclet.2024.109855
9. [9]
  Mei Peng , Wei-Min He . Photochemical synthesis and group transfer reactions of azoxy compounds. Chinese Chemical Letters, 2024, 35(8): 109899-. doi: 10.1016/j.cclet.2024.109899
10. [10]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
11. [11]
  Boran Cheng , Lei Cao , Chen Li , Fang-Yi Huo , Qian-Fang Meng , Ganglin Tong , Xuan Wu , Lin-Lin Bu , Lang Rao , Shubin Wang . Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters, 2024, 35(6): 108969-. doi: 10.1016/j.cclet.2023.108969
12. [12]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
13. [13]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
14. [14]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
15. [15]
  Chen Lian , Si-Han Zhao , Hai-Lou Li , Xinhua Cao . A giant Ce-containing poly(tungstobismuthate): Synthesis, structure and catalytic performance for the decontamination of a sulfur mustard simulant. Chinese Chemical Letters, 2024, 35(10): 109343-. doi: 10.1016/j.cclet.2023.109343
16. [16]
  Guoping Yang , Zhoufu Lin , Xize Zhang , Jiawei Cao , Xuejiao Chen , Yufeng Liu , Xiaoling Lin , Ke Li . Assembly of Y(Ⅲ)-containing antimonotungstates induced by malic acid with catalytic activity for the synthesis of imidazoles. Chinese Chemical Letters, 2024, 35(12): 110274-. doi: 10.1016/j.cclet.2024.110274
17. [17]
  Ruikui YAN , Xiaoli CHEN , Miao CAI , Jing REN , Huali CUI , Hua YANG , Jijiang WANG . Design, synthesis, and fluorescence sensing performance of highly sensitive and multi-response lanthanide metal-organic frameworks. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 834-848. doi: 10.11862/CJIC.20230301
18. [18]
  Jingqi Ma , Huangjie Lu , Junpu Yang , Liangwei Yang , Jian-Qiang Wang , Xianlong Du , Jian Lin . Rational design and synthesis of a uranyl-organic hybrid for X-ray scintillation. Chinese Journal of Structural Chemistry, 2024, 43(5): 100275-100275. doi: 10.1016/j.cjsc.2024.100275
19. [19]
  Yueying Yang , Huiru Xie , Xinbo Yu , Yang Liu , Hui Wang , Hua Li , Lixia Chen . Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells. Chinese Chemical Letters, 2024, 35(11): 109570-. doi: 10.1016/j.cclet.2024.109570
20. [20]
  Dongdong YANG , Jianhua XUE , Yuanyu YANG , Meixia WU , Yujia BAI , Zongxuan WANG , Qi MA . Design and synthesis of two coordination polymers for the rapid detection of ciprofloxacin based on triphenylpolycarboxylic acid ligands. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2466-2474. doi: 10.11862/CJIC.20240266

Get Citation

PDF

XML

Metrics

PDF Downloads(3)
Abstract views(145)
HTML views(11)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142